Symphony shares jump 12%: Firm surpasses annual revenue of ₹1,500 crore in FY25, Q4 profit surges 63%: Check top takeaways

The stock price surged as the company reported a strong set of numbers for the quarter ended March 31, 2025 (Q4 FY25) as well as the fiscal year 2024-25.

Commenting on the consolidated numbers, Nrupesh Shah, Managing Director (Corporate Affairs), Symphony, said, "Our company has achieved significant milestones in the fiscal year 2025. We surpassed an annual revenue of ₹1,500 crore, reaching ₹1,576 crore (growth of 36%) and marked the highest ever March quarter revenue, a 47% increase compared to the same period last year. We also recorded the highest annual and quarterly EBITDA and PAT."

As regards standalone performance, Shah said that the company crossed the ₹1,000 crore annual revenue mark, achieving ₹1,182 crore, a 49% year-on-year increase.

"Similar to our consolidated results, we recorded the highest March quarter revenue coupled with the highest ever annual and quarterly EBITDA and PBT (before exceptional items). EBITDA margin expanded by 512 basis points at the consolidated level and 404 basis points at the stand-alone level, driven by the successful launch of 17 new air cooler models, gross margin expansion, economies of scale, operating leverage, diverse sales channels, better penetration in semi-urban and rural areas, etc.," Shah added.

Key numbers (Q4 Consolidated)

EBITDA margin jumped 358 basis points (bps) to 21.22% against 17.64% in the March 2024 quarter.

Net profit, or PAT (profit after tax), saw an increase of 63% YoY to ₹79 crore.

Full fiscal year

For the year 2024-25, consolidated revenue from operations jumped 36% YoY to ₹1,576 crore, while EBITDA zoomed 83% YoY to ₹316 crore. EBITDA margin increased by a whopping 512 bps to 20.05%.

Net profit came in at ₹250 crore.

Dividend Update

The company's board recommended a final dividend of ₹8 per share (face value: ₹2) for FY25. This final dividend will bring the total shareholders' payout to ₹178.4 crore, representing 84% of the consolidated PAT for the fiscal year.

Subsidiaries’ performance

The company said that its subsidiary in China, Guangdong Symphony Keruilai (GSK), demonstrated robust financial performance both domestically and internationally. Notably, it repaid a loan of ₹13.5 crore to Symphony India from internal accruals, reducing the outstanding balance to ₹49.6 crore. It has also entered into a technology transfer agreement with IMPCO Mexico, valued at approximately $5 million (₹43.5 crore).

"We also wrote back 9.28 crore impairment provisions earlier made towards equity investment and loans in GSK, China, due to its strong financial performance, cash flow, and profitability," the company added.

In Brazil, the company said, its trading subsidiary continued to perform well, benefiting from strategic expansion in one of the world's largest air-cooler markets.

"IMPCO Mexico is witnessing consistent financial growth through broader product offerings and wider distribution reach. The Technology Transfer Agreement with GSK China is poised to further expand our leadership in the plastic air cooler market in Mexico," the releases added.

"Our Australian subsidiary, CT, reversed an 11-quarter trend of year-on-year revenue decline, starting in the June 2022 quarter. This positive momentum is attributed to an expanded product portfolio, broader geographical and distribution reach, and cost optimisation efforts," the company added.

Management commentary on outlook

Symphony said that the Indian summer of 2025 began with a promising start, and since then, the momentum has been mild due to the erratic summer.

"We continue to focus across semi-urban and rural markets, as well as in the modern trade channel. Our strategic focus remains on scaling these growth markets, accelerating digital expansion, and deepening partnerships with modern trade," it added.

Strategic plan

In a strategic move to sharpen our management's focus, Symphony said that it plans to exit from CT Australia and IMPCO Mexico, allowing us to concentrate on core, growing, and highly profitable products and markets.

"This decision will optimise our capital allocation and return on capital employed (ROCE). The USA market remains a highly attractive prospect, and we aim to leverage our proven track record to achieve sustainable growth and profitability," it added.

Symphony stock performance

Shares of Symphony have fallen over 23% in the past six months and nearly 9% so far in 2025. In the past month, the stock price has gained 8%.